Class Action Lawsuits
In July 2011, a proposal to certify a Yasmin and Yaz class action lawsuit was rejected by a federal judge in Illinois. Judge David Herndon—who rejected the class action proposal—is also overseeing the multidistrict litigation (MDL) concerning women who suffered blood clots or other side effects after taking Yaz or Yasmin.
MDLs differ from class action lawsuits in that each individual’s case remains separate during the proceedings, even though the cases are consolidated in a single court to make the process more efficient. In a class action lawsuit, all of the cases are consolidated into a single suit, usually in order to pay for the costs of medical monitoring for patients who used the drug.
In the case of the proposed Yasmin and Yaz class action, Judge Herndon ruled that the group of patients that would have been covered under the lawsuit was too diverse to allow for a workable medical monitoring plan to be put into effect. Although the class action plan for American patients was rejected, Canadian patients may still be eligible to join one of the Yaz and Yasmin class action lawsuits that has been filed there.
Patients in the US who suffered blood clots, pulmonary embolism, deep vein thrombosis (DVTs) or other side effects after using Yaz or Yasmin may be eligible to file a lawsuit individually. More than 10,000 Yasmin and Yaz lawsuits have been filed in the US by patients who were injured after taking these drugs.
If you or a loved one were injured after using Yaz or Yasmin, you may qualify to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.